Clinical Trial Detail

NCT ID NCT02756572
Title Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myelodysplastic Syndrome or Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of Washington
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Sirolimus

Mycophenolate mofetil

Cyclosporine

Cytarabine

Melphalan

Cladribine

Filgrastim

mitoxantrone hydrochloride

Fludarabine

Age Groups:

No variant requirements are available.